Filter Results:
(1,943)
Show Results For
- All HBS Web
(1,943)
- People (2)
- News (449)
- Research (1,072)
- Events (5)
- Multimedia (2)
- Faculty Publications (397)
Show Results For
- All HBS Web
(1,943)
- People (2)
- News (449)
- Research (1,072)
- Events (5)
- Multimedia (2)
- Faculty Publications (397)
Page 1 of 1,943
Results →
- September 2014 (Revised January 2017)
- Teaching Note
Access Health CT: Marketing Affordable Care (A) & (B)
By: John A. Quelch
Keywords: Affordable Care Act (ACA); Marketing Communications; Market Segmentation; Marketing Management; Startup Management; Analysis; Innovation and Invention; Marketing; Measurement and Metrics; Outcome or Result; Performance; Strategy; Health Industry; Insurance Industry; North and Central America
- October 2014 (Revised April 2023)
- Case
Gilead: Hepatitis C Access Strategy (A)
By: V. Kasturi Rangan, Vikram Rangan and David E. Bloom
Gilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the... View Details
Keywords: Healthcare; Pharmaceuticals; Pricing; Access To Care; Emerging Markets; Health Care and Treatment; Price; Strategy; Ethics; Health Industry; Pharmaceutical Industry
Rangan, V. Kasturi, Vikram Rangan, and David E. Bloom. "Gilead: Hepatitis C Access Strategy (A)." Harvard Business School Case 515-025, October 2014. (Revised April 2023.)
- June 2014 (Revised November 2016)
- Case
Access Health CT: Marketing Affordable Care (A)
By: John A. Quelch and Michael Norris
At the close of open-enrollment in March of 2014, Kevin Counihan, CEO of Access Health CT, Connecticut's state health insurance exchange, stops to consider the success it has experienced so far and think about how to ensure its long-term sustainability. View Details
Keywords: Health Care; Health Care Industry; Health Care Policy; Public Health Insurance Exchange; Health Care and Treatment; Health Industry; Connecticut
Quelch, John A., and Michael Norris. "Access Health CT: Marketing Affordable Care (A)." Harvard Business School Case 514-119, June 2014. (Revised November 2016.) (Title updated to reflect publication of (B) case.)
- December 2016
- Supplement
Access Health CT: Marketing Affordable Care (B)
By: John A. Quelch and Emily C. Boudreau
Supplements the (A) case. View Details
Quelch, John A., and Emily C. Boudreau. "Access Health CT: Marketing Affordable Care (B)." Harvard Business School Supplement 517-070, December 2016.
- September 2002
- Article
Universal Access and Local Commercial Internet Markets
By: Tom Downes and Shane Greenstein
Downes, Tom, and Shane Greenstein. "Universal Access and Local Commercial Internet Markets." Research Policy 31, no. 7 (September 2002): 1035–1052.
- Article
Regulatory, Legal, and Market Aspects of Smart Wearables for Cardiac Monitoring
By: Jan Benedikt Brönneke, Jennifer Müller, Konstantinos Mouratis, Julia Hagen and Ariel Dora Stern
In the area of cardiac monitoring, the use of digitally driven technologies is on the rise. While the development of medical products is advancing rapidly, allowing for new use-cases in cardiac monitoring and other areas, regulatory and legal requirements that govern... View Details
Keywords: Wearables; Regulatory Changes; Medical Technology; Medical Devices; Market Access; Market Entry and Exit; Information Technology; Health Care and Treatment; Governing Rules, Regulations, and Reforms; United States; Germany; Belgium
Brönneke, Jan Benedikt, Jennifer Müller, Konstantinos Mouratis, Julia Hagen, and Ariel Dora Stern. "Regulatory, Legal, and Market Aspects of Smart Wearables for Cardiac Monitoring." Art. 4937. Sensors 21, no. 14 (July 2021).
- April 2020 (Revised October 2021)
- Case
SpaceX, Economies of Scale, and a Revolution in Space Access
By: Matthew C. Weinzierl, Kylie Lucas and Mehak Sarang
From the time he transformed the world of online banking, Elon Musk established himself as a bold innovator. After selling X.com to PayPal in 2002, he founded a series of revolutionary start-ups, starting with Space Exploration Technologies (SpaceX). Hoping to "make... View Details
Keywords: Space Tech; Space Access; Vision; Economies Of Scale; Technological Innovation; Emerging Markets; Commercialization; Finance; Aerospace Industry
Weinzierl, Matthew C., Kylie Lucas, and Mehak Sarang. "SpaceX, Economies of Scale, and a Revolution in Space Access." Harvard Business School Case 720-027, April 2020. (Revised October 2021.)
- October 2013 (Revised January 2015)
- Case
The Slingshot: Improving Water Access
By: John A. Quelch, Margaret L. Rodriguez and Carin-Isabel Knoop
In 2012, over 750 million people around the globe lacked access to safe drinking water. Dean Kamen, inventor of the Segway, sought to bring fresh water to poor and rural areas with the Slingshot, a water purification device. Kamen's challenge was to identify ways to... View Details
Keywords: Water; Public Health; Health Care; Slingshot; Dean Kamen; DEKA; Coca-Cola; Developing Markets; Freestyle; Safety; Natural Environment; Pollutants; Health; Distribution Channels; Developing Countries and Economies; Innovation and Invention; Africa; Latin America; South America; Asia
Quelch, John A., Margaret L. Rodriguez, and Carin-Isabel Knoop. "The Slingshot: Improving Water Access." Harvard Business School Case 514-007, October 2013. (Revised January 2015.)
- 12 Jan 2006
- News
What Do 'Hot Mamas' Want? Access to Capital, Markets
- Article
Technological Mediation and Commercial Development in the Early Internet Access Market
By: Shane Greenstein
Greenstein, Shane. "Technological Mediation and Commercial Development in the Early Internet Access Market." California Management Review 43, no. 2 (Winter 2001): 75–94.
- Web
Accessibility | About
Accessibility website 2023 Digital Accessibility policy update Policy update frequently asked questions Digital Accessibility Liaisons (DAL) for each school, including HBS How... View Details
- 11 Jun 2020
- Working Paper Summaries
Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design
- October 2014 (Revised July 2016)
- Supplement
Gilead: Hepatitis C Access Strategy (B)
While the "Gilead: Hepatitis-C Access Strategy (A)" case (HBS No. 515-025) poses questions on what the company should do with respect to hard-hit countries like Egypt and India, the (B) case provides the answer. In both cases, the company chose to pursue a proactive... View Details
Rangan, V. Kasturi. "Gilead: Hepatitis C Access Strategy (B)." Harvard Business School Supplement 515-044, October 2014. (Revised July 2016.)
- Article
Targeting Weather Insurance Markets
By: Anita Mukherjee, Shawn Cole and Jeremy Tobacman
The suitability of insurance products often depends greatly on individual circumstances. This paper examines the challenges of heterogeneity in a relatively new product, weather‐indexed insurance. This index insurance product has been launched in over a dozen... View Details
Keywords: Index Insurance; Labor Markets; Self-insurance; Self-protection; Weather; Insurance; Markets; Household; Risk Management
Mukherjee, Anita, Shawn Cole, and Jeremy Tobacman. "Targeting Weather Insurance Markets." Journal of Risk and Insurance 88, no. 3 (September 2021): 757–784.
- November 2016
- Case
QuintilesIMS: Biosimilar Marketing in England
By: John A. Quelch and Emily C. Boudreau
QuintilesIMS was a leading healthcare consulting firm best known for its data and information offerings as well as its market research and management consulting services for life science companies. By 2015, the company was expanding beyond the biopharmaceutical... View Details
Keywords: Health; Pharmaceutical Industry; Biotech; Marketing; Health Care and Treatment; Biotechnology Industry; England
Quelch, John A., and Emily C. Boudreau. "QuintilesIMS: Biosimilar Marketing in England." Harvard Business School Case 517-054, November 2016.
- 2020
- Working Paper
Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design
By: Scott Duke Kominers, Parag A. Pathak, Tayfun Sönmez and M. Utku Ünver
COVID-19 convalescent plasma (CCP) therapy is currently a leading treatment for COVID-19. At present, there is a shortage of CCP relative to demand. We develop and analyze a model of centralized CCP allocation that incorporates both donation and distribution. In order... View Details
Keywords: COVID-19; Convalescent Plasma; Vouchers; Health Pandemics; Health Care and Treatment; Resource Allocation; Market Design
Kominers, Scott Duke, Parag A. Pathak, Tayfun Sönmez, and M. Utku Ünver. "Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design." Harvard Business School Working Paper, No. 20-116, May 2020. (NBER Working Paper Series, No. 27143, May 2020.)
- 2008
- Chapter
Innovation and the Evolution of Market Structure for Internet Access in the United States
By: Shane Greenstein
Greenstein, Shane. "Innovation and the Evolution of Market Structure for Internet Access in the United States." Chap. 3 in The Internet and American Business, edited by William Aspray and Paul Ceruzzi, 47–104. MIT Press, 2008.
- 07 Sep 2021
- News
Increasing Access and Expanding Opportunity
in the world, we don’t want people to be constrained by financial barriers that would prevent them from accessing the School or being successful in the MBA Program or thereafter. So, we think about this as a journey through three time... View Details
Keywords: Jennifer Gillespie
- February 2014
- Teaching Note
The Slingshot: Improving Water Access
By: John A. Quelch
Entrepreneur Dean Kamen has inked a multimillion dollar partnership with Coca-Cola (CC) to mass produce and distribute the Slingshot, a low energy device that can convert raw sewage into potable water for poor people and communities in developing economies. View Details
- October 2009 (Revised July 2013)
- Case
Gilead Sciences, Inc.: Access Program
By: V. Kasturi Rangan and Katharine Lee
Gilead Sciences, the U.S. leader in HIV/AIDS medicines, with global sales of $5.4 billion in 2009, had undertaken several innovative actions to make its anti-viral products available to over 100 low- and middle-income countries. Having reached nearly 680,000 patients... View Details
Keywords: Health Care and Treatment; Emerging Markets; Product; Sales; Competitive Strategy; Biotechnology Industry; Pharmaceutical Industry
Rangan, V. Kasturi, and Katharine Lee. "Gilead Sciences, Inc.: Access Program." Harvard Business School Case 510-029, October 2009. (Revised July 2013.)